With a deep background in medical technology and a keen eye on the oncology space, Faisal Zain has tracked the evolution of immunotherapies from promising concepts to clinical realities. Today, we delve into the high-stakes world of T cell engagers, exploring Bristol Myers Squibb's renewed bet
The widespread integration of artificial intelligence into breast cancer screening has marked a pivotal moment in medical diagnostics, yet its ultimate success hinges less on algorithmic power and more on a critical, decidedly human factor: patient trust. As healthcare systems begin to deploy these
The precision of modern medical imaging promises a clear path to diagnosis and treatment, yet for patients with soft tissue sarcomas, this promise is frequently broken by inconsistent and incomplete data gathered at the most critical early stages. While magnetic resonance imaging stands as the
Generative Artificial Intelligence is rapidly moving from a theoretical concept into a tangible, and sometimes turbulent, force within clinical settings, promising to revolutionize healthcare while simultaneously introducing unprecedented risks to patient safety. This technology represents a
In the evolving landscape of healthcare, few are better positioned to discuss the fusion of technology and patient care than Faisal Zain. As a leading expert in medical technology, with deep experience in the manufacturing and innovation of diagnostic and treatment devices, he offers a unique
A significant gap in women's healthcare is being addressed with the official launch of a new AI-powered platform from Amissa, a startup backed by a National Institutes of Health grant designed to revolutionize how clinicians manage the menopausal transition. For millions of women, the journey
